Sarah Weske

457 total citations
13 papers, 348 citations indexed

About

Sarah Weske is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Sarah Weske has authored 13 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Surgery and 4 papers in Physiology. Recurrent topics in Sarah Weske's work include Sphingolipid Metabolism and Signaling (9 papers), Erythrocyte Function and Pathophysiology (4 papers) and Cholesterol and Lipid Metabolism (3 papers). Sarah Weske is often cited by papers focused on Sphingolipid Metabolism and Signaling (9 papers), Erythrocyte Function and Pathophysiology (4 papers) and Cholesterol and Lipid Metabolism (3 papers). Sarah Weske collaborates with scholars based in Germany and United States. Sarah Weske's co-authors include Bodo Levkau, Petra Keul, Gerd Heusch, Markus H. Gräler, Karin von Wnuck Lipinski, Katherine Sattler, Raimund Erbel, Amin Polzin, Roger A. Sabbadini and Martina Bröcker‐Preuß and has published in prestigious journals such as Nature Medicine, Nature Communications and Blood.

In The Last Decade

Sarah Weske

13 papers receiving 346 citations

Peers

Countries citing papers authored by Sarah Weske

Since Specialization

Citations

This map shows the geographic impact of Sarah Weske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Weske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Weske more than expected).

Fields of papers citing papers by Sarah Weske

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Weske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Weske. The network helps show where Sarah Weske may publish in the future.

Co-authorship network of co-authors of Sarah Weske

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Weske. A scholar is included among the top collaborators of Sarah Weske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Weske. Sarah Weske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Intracellular Sphingosine‐1‐Phosphate Induces Lipolysis Through Direct Activation of Protein Kinase C Zeta 2025 ·The FASEB Journal ·Sarah Weske, (unknown), Alex Zaufel, (unknown), Christoph Peter, Lisa Walz, H. Georg Kuhn, (unknown), (unknown), (unknown), (unknown), (unknown), Bodo Levkau	3
2	Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor–dependent manner 2024 ·Journal of Bone and Mineral Research ·(unknown), Sarah Weske, Karin von Wnuck Lipinski, (unknown), (unknown), (unknown), (unknown), (unknown), Björn Behr, Petra Keul, Bodo Levkau	5
3	Sphingosine-1-phosphate suppresses GLUT activity through PP2A and counteracts hyperglycemia in diabetic red blood cells 2023 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Shahrooz Ghaderi, Karin von Wnuck Lipinski, (unknown), (unknown), (unknown), Markus H. Gräler, Lisa Dannenberg, (unknown), Philipp Westhoff, Amin Polzin, Malte Kelm, Petra Keul, Sarah Weske, Bodo Levkau	9
4	Pharmacological elevation of sphingosine‐1‐phosphate by S1P lyase inhibition accelerates bone regeneration after post‐traumatic osteomyelitis 2023 ·Journal of Cellular and Molecular Medicine ·Johannes Maximilian Wagner, (unknown), (unknown), Sarah Weske, Sebastian Lotzien, (unknown), Christoph Wallner, Alexander Sogorski, (unknown), Mustafa Becerikli, Thomas A. Schildhauer, Marcus Lehnhardt, Bodo Levkau, Björn Behr	3
5	Sphingosine-1-Phosphate Improves Outcome of No-Reflow Acute Myocardial Infarction Via Sphingosine-1-Phosphate Receptor 1 2022 ·ESC Heart Failure ·Amin Polzin, Lisa Dannenberg, (unknown), (unknown), Petra Keul, (unknown), Sarah Weske, (unknown), (unknown), Carolin Helten, Sebastian M Haberkorn, Ulrich Flögel, Tobias Zeus, Tina Müller, Markus H. Gräler, Malte Kelm, Bodo Levkau	8
6	Sphingosine-1-Phosphate (S1P) Lyase Inhibition Aggravates Atherosclerosis and Induces Plaque Rupture in ApoE−/− Mice 2022 ·International Journal of Molecular Sciences ·Petra Keul, (unknown), Karin von Wnuck Lipinski, (unknown), (unknown), (unknown), Amin Polzin, Sarah Weske, Markus H. Gräler, Bodo Levkau	9
7	Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy 2021 ·Pharmacology & Therapeutics ·Lisa Dannenberg, Sarah Weske, Malte Kelm, Bodo Levkau, Amin Polzin	30
8	Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages 2019 ·Journal of Lipid Research ·(unknown), (unknown), (unknown), Petra Keul, Sarah Weske, Markus H. Gräler, Emil Mladenov, George Iliakis, Gerd Heusch, Bodo Levkau	45
9	Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice 2019 ·Bone ·Sarah Weske, (unknown), Karin von Wnuck Lipinski, Petra Keul, (unknown), Christoph Burkhart, Gebhard Haberhauer, Gerd Heusch, Bodo Levkau	25
10	Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss 2018 ·Nature Medicine ·Sarah Weske, (unknown), A. Reese, Karin von Wnuck Lipinski, Petra Keul, (unknown), Jens W. Fischer, Ulrich Flögel, (unknown), Matthias Epple, Marta Scatena, Edzard Schwedhelm, Marcus Dörr, Henry Völzke, Eileen Moritz, Anke Hannemann, Bernhard H. Rauch, Markus H. Gräler, Gerd Heusch, Bodo Levkau	96
11	Hepatocyte nuclear factor 1A deficiency causes hemolytic anemia in mice by altering erythrocyte sphingolipid homeostasis 2017 ·Blood ·Karin von Wnuck Lipinski, Sarah Weske, Petra Keul, (unknown), Hideo A. Baba, Gerd Heusch, Markus H. Gräler, Bodo Levkau	11
12	Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice 2016 ·The Journal of Immunology ·Karin von Wnuck Lipinski, Katherine Sattler, (unknown), Sarah Weske, Petra Keul, Hannes Klump, Gerd Heusch, Joachim R. Göthert, Bodo Levkau	13
13	Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content 2015 ·Journal of the American College of Cardiology ·Katherine Sattler, Markus H. Gräler, Petra Keul, Sarah Weske, (unknown), (unknown), Petra Kleinbongard, Roger A. Sabbadini, Martina Bröcker‐Preuß, Raimund Erbel, Gerd Heusch, Bodo Levkau	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact